{"organizations": [], "uuid": "61e7d00fcdefd183a6d65cc48652fa9924400b0f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/legal", "section_title": "Legal News | Reuters", "url": "https://www.reuters.com/article/products-risperdal/risperdal-plaintiffs-can-seek-punitive-damages-pennsylvania-court-idUSL1N1P41RI", "country": "US", "domain_rank": 408, "title": "Risperdal plaintiffs can seek punitive damages -Pennsylvania court", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.997, "site_type": "news", "published": "2018-01-10T05:21:00.000+02:00", "replies_count": 0, "uuid": "61e7d00fcdefd183a6d65cc48652fa9924400b0f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/products-risperdal/risperdal-plaintiffs-can-seek-punitive-damages-pennsylvania-court-idUSL1N1P41RI", "ord_in_thread": 0, "title": "Risperdal plaintiffs can seek punitive damages -Pennsylvania court", "locations": [], "entities": {"persons": [], "locations": [{"name": "pennsylvania", "sentiment": "none"}], "organizations": [{"name": "johnson & johnson", "sentiment": "negative"}, {"name": "superior court of pennsylvania", "sentiment": "none"}, {"name": "j&j", "sentiment": "none"}, {"name": "janssen pharmaceuticals", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "More than 6,400 patients in the litigation over Johnson & Johnsonâ€™s antipsychotic drug Risperdal will be able to make claims for punitive damages over allegations that the drug caused young men to develop breasts, a Pennsylvania state appeals court ruled on Monday.\nIn a unanimous decision, a two-judge panel of the Superior Court of Pennsylvania overturned a 2014 trial court decision that barred plaintiffs from asserting punitive damages in the mass tort over J&J&rsquo;s and its Janssen Pharmaceuticals subsidiary alleged failure to warn of the risk of enlarged male breasts, a condition known as gynecomastia.\nTo read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2FmsVZ8\n ", "external_links": ["http://bit.ly/2FmsVZ8", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-10T05:21:00.000+02:00", "crawled": "2018-01-10T03:12:33.000+02:00", "highlightTitle": ""}